当前位置：首页>产品中心>单抗/多抗
单抗/多抗
产品名称 点击数
Anti-Lebrikizumab Non-Neutralizing Recombinant Antibody |抗来瑞珠单抗非中和重组抗体(靶标：来瑞珠单抗非中和抗体) 903
Anti-Lebrikizumab Non-Neutralizing Recombinant Antibody |抗来瑞珠单抗非中和重组抗体(靶标：来瑞珠单抗非中和抗体) 823
Anti-Lebrikizumab Neutralizing Recombinant Antibody |抗来瑞珠单抗中和重组抗体(靶标：来瑞珠单抗中和抗体) 953
Anti-Lebrikizumab Neutralizing Recombinant Antibody |抗来瑞珠单抗中和重组抗体(靶标：来瑞珠单抗中和抗体) 733
Anti-Lebrikizumab Neutralizing Recombinant Antibody |抗来瑞珠单抗中和重组抗体(靶标：来瑞珠单抗中和抗体) 855
Anti-Obinutuzumab Non-Neutralizing Recombinant Antibody |抗奥滨尤妥珠单抗非中和重组抗体(靶标：奥滨尤妥珠单抗非中和抗体) 828
Anti-Obinutuzumab Non-Neutralizing Recombinant Antibody |抗奥滨尤妥珠单抗非中和重组抗体(靶标：奥滨尤妥珠单抗非中和抗体) 680
Anti-Obinutuzumab Non-Neutralizing Recombinant Antibody |抗奥滨尤妥珠单抗非中和重组抗体(靶标：奥滨尤妥珠单抗非中和抗体) 640
Anti-Obinutuzumab Neutralizing Recombinant Antibody |抗奥滨尤妥珠单抗中和重组抗体(靶标：奥滨尤妥珠单抗中和抗体) 627
Anti-Obinutuzumab Neutralizing Recombinant Antibody |抗奥滨尤妥珠单抗中和重组抗体(靶标：奥滨尤妥珠单抗中和抗体) 661
Anti-Obinutuzumab Neutralizing Recombinant Antibody |抗奥滨尤妥珠单抗中和重组抗体(靶标：奥滨尤妥珠单抗中和抗体) 506
Anti-Natalizumab Non-Neutralizing Recombinant Antibody |抗那他珠单抗非中和重组抗体(靶标：那他珠单抗非中和抗体) 590
Anti-Natalizumab Non-Neutralizing Recombinant Antibody |抗那他珠单抗非中和重组抗体(靶标：那他珠单抗非中和抗体) 639
Anti-Natalizumab Non-Neutralizing Recombinant Antibody |抗那他珠单抗非中和重组抗体(靶标：那他珠单抗非中和抗体) 617
Anti-Natalizumab Non-Neutralizing Recombinant Antibody |抗那他珠单抗非中和重组抗体(靶标：那他珠单抗非中和抗体) 822
Anti-Natalizumab Neutralizing Recombinant Antibody |抗那他珠单抗中和重组抗体(靶标：那他珠单抗中和抗体) 649
Anti-Natalizumab Neutralizing Recombinant Antibody |抗那他珠单抗中和重组抗体(靶标：那他珠单抗中和抗体) 972
Anti-Natalizumab Neutralizing Recombinant Antibody |抗那他珠单抗中和重组抗体(靶标：那他珠单抗中和抗体) 819
Anti-Natalizumab Neutralizing Recombinant Antibody |抗那他珠单抗中和重组抗体(靶标：那他珠单抗中和抗体) 677
Anti-Sarilumab Non-Neutralizing Recombinant Antibody|抗萨瑞鲁单抗非中和重组抗体(靶标：萨瑞鲁单抗非中和抗体) 919
总计 33037 个记录，共 1652 页，当前第 1646 页 | 第一页 上一页 下一页 最末页
在线客服
  • 销售热线：
  • 15898894496(同微信)
  • 我要留言
  • 周一至周日 9:00-22:30